Ortoma AB Series B
Research Ortoma AB Series B (ORT-B) on Bullrun: market cap SEK 350.90M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerORT-B
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Market capSEK 350.90M
- Financial periodQ1 2026
- RevenueSEK 15.79M
- Net income-SEK 8.07M
- Free cash flow-SEK 4.87M
- Gross margin64.4%
Valuation Snapshot
latest market cap is SEK 350.90M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 64.64M | -SEK 19.19M | SEK 2.95M | 82.7% | -0.51 | SEK 20.77M | n/a | SEK 142.72M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-28 | SEK 350.90M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About Ortoma AB Series B
Ortoma AB (publ), a medical technology company, focuses on Al-based technology for orthopedic surgical procedures in Sweden. It offers Ortoma Treatment Solution (OTS), a server-based AI integrated orthopedic platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and post-operative follow-up;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Ortoma AB Series B's market cap?
Ortoma AB Series B's market capitalization is SEK 350.90M.
What does Ortoma AB Series B do?
Ortoma AB (publ), a medical technology company, focuses on Al-based technology for orthopedic surgical procedures in Sweden.